|
|
|
Dow AgroSciences Teams with USDA Lab to Develop West Nile Virus Vaccine
Indianapolis, IN - June 07, 2004 Dow AgroSciences LLC has signed a cooperative agreement with the U.S. Department of Agriculture-Agricultural Research Service (USDA-ARS) laboratory in Laramie, Wyo., to develop a plant-made vaccine to protect against West Nile virus. West Nile virus, which is transmitted by mosquitoes, is fatal to about one-third of infected horses, while about 2 percent of humans infected become seriously ill or die. West Nile virus is also a threat to birds. The research and development collaboration between Dow AgroSciences and the USDA-ARS Arthropod-Borne Animal Disease Research Laboratory resulted when both parties recognized the potential of producing the vaccine in plant systems. Plant-made vaccines are highly robust, which may result in needle-free delivery techniques such as through food, water or inhaled mist. In addition, an attractive safety aspect of using plant-made vaccines is that there is less chance of contamination with extraneous disease agents during use. Dow AgroSciences is a world leader in plant biotechnology and plant-made biologics for the treatment of animals. "This agreement with USDA-ARS is an exciting opportunity for us to apply our technology to bring new solutions to a real and immediate problem," said Butch Mercer, global business leader, Animal Health and Nutrition for Dow AgroSciences. "We are pleased to have the opportunity to work with USDA-ARS, which, in addition to its longstanding expertise in West Nile virus, has specialized laboratories for the development of vaccines and other biological products," Mercer said. For Editorial Information:
Robyn Heine |
||